©2021-2033. All Rights Reserved. Online Journal of Veterinary Research . You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJVR. This article may be copied once but may not be, reproduced or re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking:To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.


OJVRTM

Online Journal of Veterinary Research©

(Including Medical and Laboratory Research)

Established 1994
ISSN 1328-925X

 

Volume 26 (12): 920-948, 2022.


Functional diversity of melanoma antigen proteins.

 

Daniel A Achinko PhD1,3. Awino Maureiq Edith Ojwank2, Anton Dormer MD3.

 

1International Center of Insect Physiology and Ecology (ICIPE), Nairobi, Kenya, 2University of Nairobi, Kenya, P.O Box 30197, G.P.O, Nairobi, Kenya , 3PepVax, Inc.10411 Motor City Drive Bethesda, MD 20817, USA.

 

ABSTRACT

 

Achinko DA, Ojwank AME, Dormer A., Functional diversity of melanoma antigen proteins, Onl J Vet Res., 26 (12): 920-948, 2022. Evidence showing functional diversity of melanoma antigen proteins (MAGE) variants and interactions that could favor malignancy of tumors is described. Through protein-protein interaction networks, HDAC1, RARA, P53 and SNW1 proteins were identified as foundation for processes governing MAGE protein network. Involvement of these proteins in various cancer pathways implicated subclass A protein MAGE B2 as an essential lethal protein and potential molecule vaccine target and marker for diagnosis.

 

Key-Words: Melanoma, antigen, functional, diversity


MAIN

 

FULL-TEXT (SUBSCRIBE OR PURCHASE TITLE)